Fidelity: Pension Funds Exploring Bitcoin Investments on ETF Approval

Fidelity, a major financial services firm, says pension funds are starting to explore investing in Bitcoin, particularly after the approval of spot Bitcoin exchange-traded funds earlier this year. BREAKING: Wall Street giant Fidelity says pension funds are beginning to explore #Bitcoin and crypto Gradually, then suddenly 🚀 pic.twitter.com/8vBz4Bf02t — Bitcoin Magazine (@BitcoinMagazine) May 3, 2024 Fidelity has…

Read More

Gyre Therapeutics Stock: Under The Radar Biotech Has A Shot At MASH Approval (NASDAQ:GYRE)

alexei_tm/iStock via Getty Images Investment Overview Gyre Therapeutics (NASDAQ:GYRE) is an under the radar biotech company that achieved its listing on the Nasdaq in October last year via a merger between Catalyst Biosciences and GNI Group – according to a press release: Catalyst received stockholder approval for all proposals necessary to complete the business combination…

Read More

enVVeno: The Road To Approval Seems Open From Here On (NASDAQ:NVNO)

champpixs/iStock via Getty Images Thesis enVVeno Medical Corporation (NASDAQ:NVNO) is an undercovered microcap company focusing on treatments for vascular disease Chronic Venous Insufficiency. enVVeno has just released positive topline data of its pivotal trial in 75 patients with chronic venous insufficiency, treated with the VenoValve. Well beyond expectations, 97% of the patients showed clinical improvement…

Read More

Teva And Alvotech: Simlandi Approval Opens New Generic Market Opportunities (NYSE:TEVA)

Johnce/E+ via Getty Images Teva’s Prescription for Profit: Simlandi’s Market Shake-Up Since my December call for a “revival” in Teva Pharmaceutical Industries Limited’s (NYSE:TEVA) stock for the new year, shares are up 32%, beating the market’s performance (SPY) of 11% in the same time period. Seeking Alpha Over the weekend, Teva made a regulatory announcement…

Read More

Analysts Optimistic on Potential Approval This Year

The SEC faces deadlines ranging from May 23 to August 7 to make decisions on Ethereum ETF applications. The crypto market is buzzing with expectations as analysts predict a high likelihood of the approval of Ethereum (ETH) Exchange-Traded Funds (ETFs) in the coming months. Analysts’ Confidence and Comparisons with Bitcoin Eric Balchunas, a notable ETF…

Read More

VanEck Seeds Spot Bitcoin ETF with $72.5M as Bitwise Indicates $200M Upon SEC Approval

BlackRock and VanEck have seeded their ETFs with $10 million and $72.5 million, respectively, with Bitwise planning a whopping $200 million. Spot Bitcoin (BTC) exchange-traded fund (ETF) issuers are firing up seed investments in their prospective ETFs as they await official approval from the United States Securities and Exchange Commission (SEC). Details of recently amended…

Read More

Former SEC Chair: Spot Bitcoin ETF Approval Is Inevitable, "There's Nothing Left to Decide"

A bold statement has emerged from a former U.S. Securities and Exchange Commission (SEC) Chair Jay Clayton, suggesting that the approval of a Spot Bitcoin Exchange-Traded Fund (ETF) is inevitable, stating that “there’s nothing left to decide,” in an interview with CNBC today. The former SEC Chair’s confident proclamation hints at an imminent breakthrough in…

Read More

Applicants File Amended S-1 Forms for Spot Bitcoin ETFs with January 10 Approval in View

Applicants have submitted final S-1 amendments for proposed spot Bitcoin ETF approvals expected from Wednesday. Several prospective issuers of spot BTC exchange-traded funds have amended and finalized S-1 forms, in what is the final step in their quest for a spot Bitcoin ETF. According to reports, recent amendments were from applicants, including Fidelity Investments, VanEck,…

Read More

Nasdaq Files Amendment for BlackRock's Spot Bitcoin ETF, Nears Approval Deadline

The Nasdaq has submitted an amendment for BlackRock and Valkyrie’s Spot Bitcoin Exchange-Traded Fund (ETF) 19b-4 filings, inching closer to the looming approval deadline this coming Wednesday. The amendment filing comes was the next step forward in the regulatory process, indicating progress in the bid to secure approval from the U.S. Securities and Exchange Commission (SEC). The Nasdaq’s latest amendment filing…

Read More

VanEck Releases New Bitcoin Commercial, Ahead of Potential Spot Bitcoin ETF Approval

VanEck, a prominent investment management firm, has unveiled a interesting new Bitcoin commercial, stirring excitement and speculation within the Bitcoin community. The release comes amidst mounting anticipation surrounding the possible approval of Spot Bitcoin Exchange-Traded Funds (ETFs) by the Securities and Exchange Commission (SEC). The commercial, showcases a high-quality production recorded at PubKey, a Bitcoin bar…

Read More

Hashdex Drops Ad Ahead of Its Spot Bitcoin ETF Approval

Asset management firm Hashdex has unveiled a new advertisement amid the US Securities and Exchange Commission’s (SEC) evaluation of applications for the listing of spot Bitcoin (BTC) tickers on US exchanges for exchange-traded funds (ETFs). The advertisement, shared on December 28 on X (formerly Twitter), features an interview setting from the 1980s, where the subject…

Read More

BTC Price at $43K, ‘Smart Money’ Bets Big on Bitcoin Ahead of Potential BTC ETF Approval

The “smart money index”, which measures the net bullish bets by institutional players through Chicago Mercantile Exchange (CME) Bitcoin futures, has reached an all-time high of over 13,700 in recent days. Large investors have taken large long positions in the Bitcoin (BTC) futures market, indicating that institutional capital is flooding into the coin in anticipation…

Read More

ImmunityBio: Approval Likely Priced In, Yielding Mostly Risk For Would-Be Buyers (IBRX)

Sebastian Gorczowski/iStock via Getty Images Topline Summary and Update ImmunityBio, Inc. (NASDAQ:IBRX) is a late-stage developmental biotech trying to bring novel immunotherapy approaches for cancer treatment to market. Their first and biggest shot on goal is a combination therapy with BCG in patients with bladder cancer, with an FDA decision coming in April 2024. While…

Read More

ESG-focused 7RCC Joins Race for Bitcoin ETF Approval

7RCC’s crypto ETF differs from those of other similar products. 80% of it will consist of Bitcoin, while the rest will hold carbon credits futures Crypto asset management firm 7RCC might be the latest in a long list of firms seeking a spot Bitcoin exchange-traded fund (ETF) approval. This follows after the ESG-focused firm recently…

Read More

El Salvador’s Bitcoin-Backed Volcano Bonds Get Regulatory Approval

By securing outside funding support through the pioneering Volcano Bonds, El Salvador can continue progressing with Bitcoin integration across governmental services and society. El Salvador has successfully overcome a significant regulatory hurdle as it pursues the introduction of Bitcoin-backed sovereign debt instruments, referred to as “volcano bonds”. The nation’s Digital Assets Commission has provided the…

Read More

Vertex And CRISPR Therapeutics: Historic Exa-cel Approval, Why Market Is Nonplussed (VRTX)

Bet_Noire Investment Overview Historic Approval Validates CRISPR Gene Editing Approach News broke this afternoon that the Food and Drug Agency (“FDA”) has granted approval to a CRISPR-based gene editing therapy for the first time in history. It is an historic achievement for both Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) and CRISPR Therapeutics AG (NASDAQ:CRSP), the two companies…

Read More

eToro Receives Approval to Operate in UAE

eToro’s foray into the UAE comes amidst a period of global expansion for the platform. The retail and social trading giant eToro recently announced that it has received a license from the Abu Dhabi Global Market (ADGM) to operate as a broker in securities, derivatives, and crypto assets in the United Arab Emirates (UAE). eToro Bags…

Read More

Former NYSE President Says Money Will "Flood" Into Bitcoin Upon Spot ETF Approval

In an exclusive interview with CNBC, Tom Farley, the former President of the New York Stock Exchange (NYSE) and current CEO of Bullish, shared his optimistic outlook on the future of cryptocurrency, particularly Bitcoin, upon the potential approval of a Bitcoin spot exchange-traded fund (ETF) by the Securities and Exchange Commission (SEC). Farley’s comments come amidst…

Read More

PayPal Receives FCA Approval to Offer Crypto Services in UK

With this approval, PayPal joins firms like Interactive Brokers, Bitstamp, and Komainu that have been granted crypto registration this year. Payments company PayPal Holdings Inc (NASDAQ: PYPL) has received approval from the UK’s Financial Conduct Authority (FCA) to offer cryptocurrency services. Official FCA data shows that as of October 31, 2023, PayPal is registered for…

Read More

Catalyst Pharmaceuticals: Agamree Approval Selloff A Long-Term Buying Opportunity (CPRX)

koto_feja/E+ via Getty Images Company website Investment Thesis Rating Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Buy with 2-5 year target of $40 (3x upside) based on the discounted cash flow (“DCF”) valuation method. Steroids are used in 70% of patients with Duchenne’s muscular dystrophy, DMD, a debilitating neuromuscular disease, which is a 2 billion/year market and is…

Read More